{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:59:21Z","timestamp":1772038761048,"version":"3.50.1"},"reference-count":50,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/kxhz6884","type":"journal-article","created":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T03:13:17Z","timestamp":1727579597000},"page":"4534-4548","source":"Crossref","is-referenced-by-count":2,"title":["Analysis and insights of cardiac amyloidosis: novel perception of rare diseases in cardiology"],"prefix":"10.62347","volume":"16","author":[{"given":"He","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1093\/cvr\/cvac119","article-title":"Transthyretin cardiac amyloidosis","volume":"118","author":"Porcari","year":"2023","unstructured":"Porcari A, Fontana M and Gillmore JD. Transthyretin cardiac amyloidosis. Cardiovasc Res 2023; 118: 3517-3535.","journal-title":"Cardiovasc Res"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac amyloidosis: overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","unstructured":"Rubin J and Maurer MS. Cardiac amyloidosis: overlooked, underappreciated, and treatable. Annu Rev Med 2020; 71: 203-219.","journal-title":"Annu Rev Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","unstructured":"Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, Roger VL, Gertz MA, Dispenzieri A, Zeldenrust SR and Redfield MM. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2014; 2: 113-122.","journal-title":"JACC Heart Fail"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/AITC202303210","article-title":"Cardiac amyloidosis","volume":"176","author":"Bloom","year":"2023","unstructured":"Bloom MW and Gorevic PD. Cardiac amyloidosis. Ann Intern Med 2023; 176: 33-48.","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/00015385.2021.1992990","article-title":"Cardiac amyloidosis: a review of the literature","volume":"77","author":"de Marneffe","year":"2022","unstructured":"de Marneffe N, Dulgheru R, Ancion A, Moonen M and Lancellotti P. Cardiac amyloidosis: a review of the literature. Acta Cardiol 2022; 77: 683-692.","journal-title":"Acta Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"A position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases","volume":"23","author":"Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG and Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur J Heart Fail 2021; 23: 512-526.","journal-title":"Eur J Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, Nair AP, Nativi-Nicolau J and Ruberg FL; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation 2020; 142: e7-e22.","DOI":"10.1161\/CIR.0000000000000792"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/ajh.26569","article-title":"Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment","volume":"97","author":"Gertz","year":"2022","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment. Am J Hematol 2022; 97: 818-829.","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Martinez-Naharro A, Hawkins PN and Fontana M. Cardiac amyloidosis. Clin Med (Lond) 2018; 18 Suppl 2: s30-s35.","DOI":"10.7861\/clinmedicine.18-2-s30"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000506617","article-title":"When to suspect a diagnosis of amyloidosis","volume":"143","author":"Vaxman","year":"2020","unstructured":"Vaxman I and Gertz M. When to suspect a diagnosis of amyloidosis. Acta Haematol 2020; 143: 304-311.","journal-title":"Acta Haematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms23010025","article-title":"Molecular mechanisms of cardiac amyloidosis","volume":"23","author":"Saito","year":"2021","unstructured":"Saito Y, Nakamura K and Ito H. Molecular mechanisms of cardiac amyloidosis. Int J Mol Sci 2021; 23: 25.","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11912-017-0607-4","article-title":"Cardiac amyloidosis: diagnosis and treatment strategies","volume":"19","author":"Tuzovic","year":"2017","unstructured":"Tuzovic M, Yang EH, Baas AS, Depasquale EC, Deng MC, Cruz D and Vorobiof G. Cardiac amyloidosis: diagnosis and treatment strategies. Curr Oncol Rep 2017; 19: 46.","journal-title":"Curr Oncol Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.JAA.0000697236.11386.3a","article-title":"Understanding and recognizing cardiac amyloidosis","volume":"33","author":"McVeigh","year":"2020","unstructured":"McVeigh T and Tennyson C. Understanding and recognizing cardiac amyloidosis. JAAPA 2020; 33: 16-20.","journal-title":"JAAPA"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tcm.2019.12.003","article-title":"Transthyretin cardiac amyloidosis: a treatable form of heart failure with a preserved ejection fraction","volume":"31","author":"Griffin","year":"2021","unstructured":"Griffin JM and Maurer MS. Transthyretin cardiac amyloidosis: a treatable form of heart failure with a preserved ejection fraction. Trends Cardiovasc Med 2021; 31: 59-66.","journal-title":"Trends Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.3390\/ijms20092322","article-title":"Inflammatory and molecular pathways in heart failure-ischemia, HFpEF and transthyretin cardiac amyloidosis","volume":"20","author":"da Silva D","year":"2019","unstructured":"Michels da Silva D, Langer H and Graf T. Inflammatory and molecular pathways in heart failure-ischemia, HFpEF and transthyretin cardiac amyloidosis. Int J Mol Sci 2019; 20: 2322.","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.humpath.2023.06.007","article-title":"Gastrointestinal amyloidosis: an often unexpected finding with systemic implications","volume":"139","author":"Hagen","year":"2023","unstructured":"Hagen CE, Dasari S, Theis JD, Rech KL, Dao LN, Howard MT, Dispenzieri A, Chiu A, Dalland JC, Kurtin PJ, Gertz MA, Kourelis TV, Muchtar E, Vrana JA and McPhail ED. Gastrointestinal amyloidosis: an often unexpected finding with systemic implications. Hum Pathol 2023; 139: 27-36.","journal-title":"Hum Pathol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): a review","volume":"289","author":"Muchtar","year":"2021","unstructured":"Muchtar E, Dispenzieri A, Magen H, Grogan M, Mauermann M, McPhail ED, Kurtin PJ, Leung N, Buadi FK, Dingli D, Kumar SK and Gertz MA. Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med 2021; 289: 268-292.","journal-title":"J Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Kaiser ME and Lewis TJ. Heart of the matter: decoding the underdiagnosed cardiac amyloidosis. Cureus 2023; 15: e50527.","DOI":"10.7759\/cureus.50527"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.24875\/acme.m24000468","article-title":"Prevalence of moderate-severe aortic stenosis in patients with cardiac amyloidosis in a referral center","volume":"94","author":"Decotto","year":"2024","unstructured":"Decotto S, Corna G, Villanueva E, Arenaza DP, Seropian I, Falconi M, Oberti P, Aguirre MA, Posadas-Martínez ML, Carretero M, Agatiello CR and Pizarro R. Prevalence of moderate-severe aortic stenosis in patients with cardiac amyloidosis in a referral center. Arch Cardiol Mex 2024; 94: 71-78.","journal-title":"Arch Cardiol Mex"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Lacouture Fierro JA, Ribero Vargas DA, Sánchez Cano J, Gaviria Jaramillo LM, Perilla Suarez OG, Galvez Cárdenas KM and Ospina Ospina S. Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis. Colomb Med (Cali) 2023; 54: e2025667.","DOI":"10.25100\/cm.v54i3.5667"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"131599","DOI":"10.1016\/j.ijcard.2023.131599","article-title":"Speckle tracking echocardiography in plasma cell disorders: the role of advanced imaging in the early diagnosis of AL systemic cardiac amyloidosis","volume":"398","author":"Carli G","year":"2024","unstructured":"De Carli G, Mandoli GE, Salvatici C, Biagioni G, Marallo C, Turchini F, Ghionzoli N, Melani A, Pastore MC, Gozzetti A, D’Ascenzi F, Cavigli L, Giacomin E, Cameli M and Focardi M. Speckle tracking echocardiography in plasma cell disorders: the role of advanced imaging in the early diagnosis of AL systemic cardiac amyloidosis. Int J Cardiol 2024; 398: 131599.","journal-title":"Int J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13023-020-1300-5","article-title":"Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study","volume":"15","author":"EK","year":"2020","unstructured":"Schmidt EK, Mustonen T, Kiuru-Enari S, Kivelä TT and Atula S. Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study. Orphanet J Rare Dis 2020; 15: 19.","journal-title":"Orphanet J Rare Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.hfc.2022.02.005","article-title":"Cardiac amyloidosis","volume":"18","author":"Gertz","year":"2022","unstructured":"Gertz MA. Cardiac amyloidosis. Heart Fail Clin 2022; 18: 479-488.","journal-title":"Heart Fail Clin"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.5603\/cj.97076","article-title":"Serial electrocardiographic and echocardiographic assessments of cardiac amyloidosis presenting with myocardial ischemia","volume":"30","author":"Konishi","year":"2023","unstructured":"Konishi T and Hamabe A. Serial electrocardiographic and echocardiographic assessments of cardiac amyloidosis presenting with myocardial ischemia. Cardiol J 2023; 30: 1059-1060.","journal-title":"Cardiol J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/jcm13020368","article-title":"Amyloid burden correlates with electrocardiographic findings in patients with cardiac amyloidosis-insights from histology and cardiac magnetic resonance imaging","volume":"13","author":"Duca","year":"2024","unstructured":"Duca F, Rettl R, Kronberger C, Poledniczek M, Binder C, Dalos D, Koschutnik M, Donà C, Beitzke D, Loewe C, Nitsche C, Hengstenberg C, Badr-Eslam R, Kastner J, Bergler-Klein J and Kammerlander AA. Amyloid burden correlates with electrocardiographic findings in patients with cardiac amyloidosis-insights from histology and cardiac magnetic resonance imaging. J Clin Med 2024; 13: 368.","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/ehf2.14655","article-title":"Novel electrocardiographic criteria may render possible the more accurate recognition of cardiac amyloidosis","volume":"11","author":"Vereckei","year":"2024","unstructured":"Vereckei A, Katona G, Szénási G, Vidács LD, Földeák D, Takács H, Nagy V and Sepp R. Novel electrocardiographic criteria may render possible the more accurate recognition of cardiac amyloidosis. ESC Heart Fail 2024; 11: 1030-1038.","journal-title":"ESC Heart Fail"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/ehjci\/jeae021","article-title":"Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study","volume":"25","author":"Cotella","year":"2024","unstructured":"Cotella J, Randazzo M, Maurer MS, Helmke S, Scherrer-Crosbie M, Soltani M, Goyal A, Zareba K, Cheng R, Kirkpatrick JN, Yogeswaran V, Kitano T, Takeuchi M, Fernandes F, Hotta VT, Campos Vieira ML, Elissamburu P, Ronderos R, Prado A, Koutroumpakis E, Deswal A, Pursnani A, Sarswat N, Addetia K, Mor-Avi V, Asch FM, Slivnick JA and Lang RM. Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging 2024; 25: 754-761.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Zheng Y, Liu X, Yang K, Chen X, Wang J, Zhao K, Dong W, Yin G, Yu S, Yang S, Lu M, Su G and Zhao S. Cardiac MRI feature-tracking-derived torsion mechanics in systolic and diastolic dysfunction in systemic light-chain cardiac amyloidosis. Clin Radiol 2024; 79: e692-e701.","DOI":"10.1016\/j.crad.2023.12.027"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.21037\/cdt-23-205","article-title":"Early diagnostic and prognostic value of myocardial strain derived from cardiovascular magnetic resonance in patients with cardiac amyloidosis","volume":"13","author":"Hou","year":"2023","unstructured":"Hou W, Wang Z, Huang J, Fan F, Yang F, Qiu L, Zhao K, Qiu J, Yang Y, Ma W, Gong Y and Hong T. Early diagnostic and prognostic value of myocardial strain derived from cardiovascular magnetic resonance in patients with cardiac amyloidosis. Cardiovasc Diagn Ther 2023; 13: 979-993.","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Boretto P, Patel NH, Patel K, Rana M, Saglietto A, Soni M, Ahmad M, Sin Ying Ho J, De Filippo O, Providencia RA, Hyett Bray JJ and D’Ascenzo F. Prognosis prediction in cardiac amyloidosis by cardiac magnetic resonance imaging: a systematic review with meta-analysis. Eur Heart J Open 2023; 3: oead092.","DOI":"10.1093\/ehjopen\/oead092"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2967\/jnumed.123.266767","article-title":"Reply: recent evidence on cardiac (99m)Tc-DPD uptake after therapy with tafamidis may reveal the road to an ultra-early diagnosis in patients with ATTR amyloidosis","volume":"65","author":"Rischpler","year":"2024","unstructured":"Rischpler C, Kersting D, Kessler L, Varasteh Z, Luedike P, Carpinteiro A, Rassaf T, Herrmann K and Papathanasiou M. Reply: recent evidence on cardiac (99m)Tc-DPD uptake after therapy with tafamidis may reveal the road to an ultra-early diagnosis in patients with ATTR amyloidosis. J Nucl Med 2024; 65: 330.","journal-title":"J Nucl Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2967\/jnumed.123.266676","article-title":"Recent evidence on cardiac (99m)Tc-DPD uptake after therapy with tafamidis may reveal the road to an ultra-early diagnosis in patients with ATTR amyloidosis","volume":"65","author":"Caobelli","year":"2024","unstructured":"Caobelli F. Recent evidence on cardiac (99m)Tc-DPD uptake after therapy with tafamidis may reveal the road to an ultra-early diagnosis in patients with ATTR amyloidosis. J Nucl Med 2024; 65: 329.","journal-title":"J Nucl Med"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Nunes ARP and Alves VM. Mitral annular calcification as a potential false-positive for cardiac amyloidosis in 99m Tc-DPD scintigraphy accurately identified by SPECT\/CT. Clin Nucl Med 2024; 49: e179-e181.","DOI":"10.1097\/RLU.0000000000005086"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Maraj D, Ramanan S, Patel PM, Memon M and Hawes E. Persistent heart failure despite medical therapy leading to a diagnosis of cardiac amyloidosis. Cureus 2023; 15: e43547.","DOI":"10.7759\/cureus.43547"},{"key":"ref34","unstructured":"Medarametla GD, Kahlon RS, Mahitha L, Shariff S, Vakkalagadda NP, Chopra H, Kamal MA, Patel N, Sethi Y and Kaka N. Cardiac amyloidosis: evolving pathogenesis, multimodal diagnostics, and principles of treatment. EXCLI J 2023; 22: 781-808."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/13506129.2019.1698417","article-title":"Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype","volume":"27","author":"Driggin","year":"2020","unstructured":"Driggin E, Helmke S, De Los Santos J, Teruya S, Guadalupe S, Goldsmith J and Maurer MS. Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype. Amyloid 2020; 27: 73-80.","journal-title":"Amyloid"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.nmd.2016.03.006","article-title":"Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy","volume":"26","author":"Russo","year":"2016","unstructured":"Russo M, Vita GL, Stancanelli C, Mazzeo A, Vita G and Messina S. Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy. Neuromuscul Disord 2016; 26: 374-377.","journal-title":"Neuromuscul Disord"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Carretero M, Villanueva E, Brulc EB, Faelo FM, Aguirre MA, Pérez-de-Arenaza D, Belziti CA, Arbelbide JA, Nucifora EM and Posadas-Martinez ML. Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis. Arch Cardiol Mex 2023; 93: 435-441.","DOI":"10.24875\/ACME.M22000424"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1111\/imj.15926","article-title":"Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis","volume":"52","author":"Brennan","year":"2022","unstructured":"Brennan X, Withers B, Jabbour A, Milliken S, Kotlyar E, Fay K, Ma D, Muthiah K, Hamad N, Dodds A, Bart N, Keogh A, Hayward C, Macdonald P and Moore J. Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis. Intern Med J 2022; 52: 1826-1830.","journal-title":"Intern Med J"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/13506129.2023.2169124","article-title":"A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed\/refractory systemic immunoglobulin light chain amyloidosis","volume":"30","author":"Ravichandran","year":"2023","unstructured":"Ravichandran S, Hall A, Jenner M, Garg M, Kishore B, Lachmann H, Gillmore J, Pitchford A, Oughton JB, Mahmood S, Sachchithantham S, Hawkins P, Brown S and Wechalekar A. A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed\/refractory systemic immunoglobulin light chain amyloidosis. Amyloid 2023; 30: 290-296.","journal-title":"Amyloid"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"67910","DOI":"10.52965\/001c.67910","article-title":"Inotersen to treat polyneuropathy associated with hereditary transthyretin (hATTR) amyloidosis","volume":"10","author":"Robinson","year":"2023","unstructured":"Robinson C, Pham C, Zamarripa AM, Dugay CS, Lee CA, Berger AA, Landman A, Cornett EM, Kassem H, Kaye AD, Urits I, Viswanath O and Ganti L. Inotersen to treat polyneuropathy associated with hereditary transthyretin (hATTR) amyloidosis. Health Psychol Res 2023; 10: 67910.","journal-title":"Health Psychol Res"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Campbell CM, Baiyee CAMT, Almaani S, Bumma N, Sharma N, LoRusso S, Redder E, Bittengle J, Pfund K, Friemer M, Tong M, Kahwash R, Efebera Y, Parikh S and Vallakati A. Targeted therapeutics for transthyretin amyloid cardiomyopathy. Am J Ther 2023; 30: e447-e453.","DOI":"10.1097\/MJT.0000000000001296"},{"key":"ref42","unstructured":"Argon A, Nart D and Yilmazbarbet F. Cardiac amyloidosis: clinical features, pathogenesis, diagnosis, and treatment. Turk Patoloji Derg 2024; 40: 1-9."},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Chen H, Chandrashekar P, Fischer K, Carlson D, Narayan U, Chen J and Masri A. Navigating the complex web of prescribing amyloidosis therapeutics: a primer. J Am Heart Assoc 2022; 11: e023895.","DOI":"10.1161\/JAHA.121.023895"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2147\/TCRM.S414821","article-title":"Status and future directions of therapeutics and prognosis of cardiac amyloidosis","volume":"19","author":"Zhang","year":"2023","unstructured":"Zhang W, Ding J, Wang W, Wang D, Pan Y and Xu D. Status and future directions of therapeutics and prognosis of cardiac amyloidosis. Ther Clin Risk Manag 2023; 19: 581-597.","journal-title":"Ther Clin Risk Manag"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pharmthera.2017.06.011","article-title":"Novel pharmacotherapies for cardiac amyloidosis","volume":"180","author":"KM","year":"2017","unstructured":"Alexander KM, Singh A and Falk RH. Novel pharmacotherapies for cardiac amyloidosis. Pharmacol Ther 2017; 180: 129-138.","journal-title":"Pharmacol Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ajt.2022.11.003","article-title":"Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: short-term outcome in a first-in-world experience","volume":"23","author":"Brubaker","year":"2023","unstructured":"Brubaker AL, Urey MA, Taj R, Parekh JR, Berumen J, Kearns M, Shah M, Khan A, Kono Y, Ajmera V, Barman P, Tran H, Adler ED, Silva Enciso J, Asimakopoulos F, Costello C, Bower R, Sanchez R, Pretorius V and Schnickel GT. Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: short-term outcome in a first-in-world experience. Am J Transplant 2023; 23: 291-293.","journal-title":"Am J Transplant"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.hfc.2024.02.002","article-title":"Pathophysiology of cardiac amyloidosis","volume":"20","author":"Morfino","year":"2024","unstructured":"Morfino P, Aimo A, Franzini M, Vergaro G, Castiglione V, Panichella G, Limongelli G and Emdin M. Pathophysiology of cardiac amyloidosis. Heart Fail Clin 2024; 20: 261-270.","journal-title":"Heart Fail Clin"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.12968\/bjon.2024.33.9.424","article-title":"Cardiac amyloidosis at a glance","volume":"33","author":"Tavares","year":"2024","unstructured":"Tavares S and Dirksen A. Cardiac amyloidosis at a glance. Br J Nurs 2024; 33: 424-429.","journal-title":"Br J Nurs"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/011573403X240302230925043500","article-title":"Cardiac amyloidosis: a contemporary review of medical and surgical therapy","volume":"20","author":"Brownell","year":"2024","unstructured":"Brownell D, Pillai AJ and Nair N. Cardiac amyloidosis: a contemporary review of medical and surgical therapy. Curr Cardiol Rev 2024; 20: 72-81.","journal-title":"Curr Cardiol Rev"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/9\/ajtr0156925.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:05Z","timestamp":1766023025000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/9\/ajtr0156925.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/kxhz6884","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}